Investigation of cause of Kawasaki disease, molecular infecto-immunolgical analysis
川崎病病因调查、分子感染免疫学分析
基本信息
- 批准号:06454310
- 负责人:
- 金额:$ 4.48万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for General Scientific Research (B)
- 财政年份:1994
- 资助国家:日本
- 起止时间:1994 至 1995
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
The etiology of KD is unknown. Some reports indicated that KD is associated with the selective expansion of Vbeta2^+ and Vbeta8.1^+T cells in peripheral blood lymphocytes (PBL). To understand better the ethiology of KD,we investigated T cell receptor (TCR) Vbeta^<2+> and Vbeta8.1^+ expansion on the T cell of freshly isolated PBL and T cell clones (TCC). Blood samples were obtained from patients with acute (n=20) and convalescent (n=20) KD,age matched children with non-infectious disease (n=18), and healthy adults (n=20). Among these four groups, there were no significant differences in the percentages of their Vbeta^<2+> and Vbeta8.1^+T cells. The same was true for the CD4^+ or CD8^+ T cell subsets. One hundred and five TCC established from the affected skin, lymphnode or PBL of six patients with KD were also negative for either Vbeta2 or Vbeta8.1 TCR.Sixty-eight of 105 TCC produced detectable levels of TNF-alpha, in the absence of any stimuli. In contrast, only 11 or 7 produced detectable levels of IL-2 or IL-6, respectively. Stimulation with phytohaemagglutinin and phorbol myristate induced most TCC to produce higher amounts of TNF-alpha, IL-2 and IL-6. These results suggest that CD4^+ T helper cells expressing TCR-beta other than Vbeta2 or Vbeta8.1 receptor, primarily through TNF-alpha production, are involved in the immunopathology of KD.In other reports that KD is associated with the selective expansion of Vbeta2 and Vbeta8.1, in vitro activated PBL were used. Therfore, their method may allow possibly allow in vitro modification of TCR usage.Fouthermore we measured TSST-1 concentrations and anti-TSST-1 antibody in serum from KD patients in both the acute and the convalescent phase. TSST-1 was reported as a possible cause of KD recently. Bur we failed to find any evidence that KD is caused by TSST-1.
KD的病因尚不清楚。有报道指出KD与外周血淋巴细胞(PBL)中Vbeta2^+和Vbeta8.1^+T细胞的选择性增殖有关。为了更好地了解KD的遗传学,我们研究了新鲜分离的PBL和T细胞克隆(TCC)的T细胞受体(TCR)Vbeta^<;2+&Gt;和Vbeta8.1^+的增殖情况。血样来自KD急性期(n=20)和恢复期(n=20)、年龄匹配的非感染性疾病儿童(n=18)和健康成人(n=20)。在这四组中,其Vbeta2+和Vbeta8.1+T细胞的百分比没有显著差异。CD4^+或CD8^+T细胞亚群也是如此。从6例KD患者的受累皮肤、淋巴结或外周血中建立的105例TCC也呈Vbeta2或Vbeta8.1TCR阴性。相比之下,只有11个或7个分别产生了可检测到的IL-2或IL-6水平。植物血凝素和佛波酯刺激大多数移行细胞产生较高数量的肿瘤坏死因子-α、白介素2和白介素6。这些结果表明,表达TCR-β而不是Vbeta2或Vbeta8.1受体的CD4^+T辅助细胞主要通过产生肿瘤坏死因子-α参与了KD的免疫病理。在其他关于KD与Vbeta2和Vbeta8.1选择性扩增有关的报道中,使用了体外激活的PBL。因此,他们的方法可能允许在体外修改TCR的用法。此外,我们检测了急性期和恢复期KD患者血清中TSST-1浓度和抗TSST-1抗体。TSST-1最近被报道为KD的可能病因。但我们没有找到任何证据表明KD是由TSST-1引起的。
项目成果
期刊论文数量(62)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Nishiyori A: "KAWASAKI DISEASE" EXCERPTA MEDICA, 5 (1995)
西赖 A:“川崎病”医学摘录,5 (1995)
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Yanagawa H: "Results twelve nationwide epidemiological incidencesurveys of Kawasaki disease in Japan." Arch Pediatr Adolesc Med. 149. 779-783 (1995)
柳川 H:“日本 12 项全国川崎病流行病学发病率调查结果。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Nakamura Y: "Incidence rate of recurrent Kawasaki disease in Japan." Acta Pediatrica. 83. 1061-1064 (1995)
Nakamura Y:“日本川崎病复发率。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Kato H: "Kawasaki disease" Coronary Artery Dis. 6. 194-206 (1995)
加藤 H:“川崎病”冠状动脉疾病。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
KATO Hirohisa其他文献
KATO Hirohisa的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('KATO Hirohisa', 18)}}的其他基金
Identification and characterization of biofilm regulatory autolysins
生物膜调节自溶素的鉴定和表征
- 批准号:
23592746 - 财政年份:2011
- 资助金额:
$ 4.48万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Development of novel drugs to control oral biofilms towards clinical application
开发控制口腔生物膜的新药并走向临床应用
- 批准号:
20592181 - 财政年份:2008
- 资助金额:
$ 4.48万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Gene therapy for induction of immunological tolerance in organ allografts
诱导同种异体器官移植免疫耐受的基因治疗
- 批准号:
13671253 - 财政年份:2001
- 资助金额:
$ 4.48万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Vasculitis in Kawasaki disease : the molecular and vascular biological studies
川崎病的血管炎:分子和血管生物学研究
- 批准号:
10470183 - 财政年份:1998
- 资助金额:
$ 4.48万 - 项目类别:
Grant-in-Aid for Scientific Research (B).
Comparative study on Kawasaki disease between Japan and North America
日本与北美川崎病的比较研究
- 批准号:
09044347 - 财政年份:1997
- 资助金额:
$ 4.48万 - 项目类别:
Grant-in-Aid for international Scientific Research
Development of the new transctaneous occlusion system for patent ductus arteriosus
新型经皮动脉导管未闭封堵系统的开发
- 批准号:
08557053 - 财政年份:1996
- 资助金额:
$ 4.48万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Study on Etiology and Pathogenesis of Kawasaki Disease
川崎病病因及发病机制研究
- 批准号:
07307011 - 财政年份:1995
- 资助金额:
$ 4.48万 - 项目类别:
Grant-in-Aid for Scientific Research (A)
cDNA cloning of the recepters for the members of TGFbeta superfamily
TGFbeta超家族成员受体的cDNA克隆
- 批准号:
05671566 - 财政年份:1993
- 资助金额:
$ 4.48万 - 项目类别:
Grant-in-Aid for General Scientific Research (C)
Morphological and hemodynamic changes of the fetal heart : chronological evaluation from fetus to newborn
胎儿心脏的形态和血流动力学变化:从胎儿到新生儿的时间顺序评估
- 批准号:
04670627 - 财政年份:1992
- 资助金额:
$ 4.48万 - 项目类别:
Grant-in-Aid for General Scientific Research (C)
相似海外基金
Machine Learning of Disease Biomarkers from B and T cell Receptor Repertoires
来自 B 和 T 细胞受体库的疾病生物标志物的机器学习
- 批准号:
23K28188 - 财政年份:2024
- 资助金额:
$ 4.48万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
The molecular basis of T cell receptor cross-reactivity between MHC and MR1
MHC 和 MR1 之间 T 细胞受体交叉反应的分子基础
- 批准号:
DP240102905 - 财政年份:2024
- 资助金额:
$ 4.48万 - 项目类别:
Discovery Projects
CAREER: Understanding the Impact of Dephosphorylation Kinetics and Adapter Specificity on Synthetic T Cell Receptor Signaling and Function
职业:了解去磷酸化动力学和接头特异性对合成 T 细胞受体信号传导和功能的影响
- 批准号:
2339172 - 财政年份:2024
- 资助金额:
$ 4.48万 - 项目类别:
Continuing Grant
Special Public T Cell Receptor Sequences that Predict Outcomes for Cancer Patients
预测癌症患者预后的特殊公共 T 细胞受体序列
- 批准号:
10577518 - 财政年份:2023
- 资助金额:
$ 4.48万 - 项目类别:
Machine Learning of Disease Biomarkers from B and T cell Receptor Repertoires
来自 B 和 T 细胞受体库的疾病生物标志物的机器学习
- 批准号:
23H03498 - 财政年份:2023
- 资助金额:
$ 4.48万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Impact of T cell receptor signaling on memory CD8+ T cell stemness
T 细胞受体信号传导对记忆 CD8 T 细胞干性的影响
- 批准号:
10676407 - 财政年份:2023
- 资助金额:
$ 4.48万 - 项目类别:
T cell receptor cross-reactivity and structural basis of virus immune escape
T细胞受体交叉反应性和病毒免疫逃逸的结构基础
- 批准号:
22KK0277 - 财政年份:2023
- 资助金额:
$ 4.48万 - 项目类别:
Fund for the Promotion of Joint International Research (Fostering Joint International Research (A))
T-cell receptor mimic affinity reagent generation using an in vivo novel immunogen strategy
使用体内新型免疫原策略生成 T 细胞受体模拟亲和试剂
- 批准号:
10599584 - 财政年份:2023
- 资助金额:
$ 4.48万 - 项目类别:
Mechanical regulation of T cell receptor and co-receptor responses in cancer immunotherapy
癌症免疫治疗中 T 细胞受体和辅助受体反应的机械调节
- 批准号:
10530023 - 财政年份:2022
- 资助金额:
$ 4.48万 - 项目类别:
Inhibition of T-cell Receptor Signaling for Treatment of Adult T-cell Leukemia Lymphoma
抑制 T 细胞受体信号转导治疗成人 T 细胞白血病淋巴瘤
- 批准号:
10684172 - 财政年份:2022
- 资助金额:
$ 4.48万 - 项目类别: